Publications by authors named "Mathias Gradl"

Claim this Profile
S
Selectivity for TP53 signalling drives the mode of action of a highly potent ,,-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate.
Alexander Rosner, Lukas Skos, Theresa Mendrina, Dina Baier, Michaela Hejl, Mathias Gradl

Chem Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin-targeted oxaliplatin(iv) prodrugs bearing STING agonists.
Martijn Dijkstra, Michael Gutmann, Mathias Gradl, Anja Federa, Carola Jaunecker

Inorg Chem Front· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Site-Selectively Functionalized Albumin with DFO*Maleimide for Zr-Radiolabeling Yields a Metabolically Stable PET Probe that Enables Late Time-Point Tumor Imaging in Mice.
Julia Kronberger, Theresa Balber, Hemma Schueffl, Raphaela Wahrmann, Anja Federa, Mathias Gradl

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis